Results 81 to 90 of about 5,120 (129)

The Puzzle of Genetic Stability and Chromosomal Copy Number Alterations for the Therapy of Ewing Sarcoma. [PDF]

Cancers (Basel)
Richter GHS, Ranft A, Kerkhoff M, Jens M, Kirchberg IE, Dirksen U.   +5 more
europepmc   +1 more source

Autocrine TGFβ2 enforces a transcriptionally hybrid cell state in Ewing sarcoma. [PDF]

Sci Adv
Wrenn ED, Harris JC, Apfelbaum AA, Valenti JR, Lipson PA, Walter SI, Garcia NM, Miyaki A, Chen SC, Olson JM, Price JP, Bailey KM, Lawlor ER.   +12 more
europepmc   +1 more source

Targeting Neuropeptide Y/DPP4 Signalling Suppresses Ewing Sarcoma Survival and Improves Monocyte Viability. [PDF]

Int J Mol Sci
Rumney RMH, Górecki DC.
europepmc   +1 more source

Modelling EWS::FLI1 protein fluctuations reveal determinants of tumor plasticity in Ewing sarcoma. [PDF]

EMBO Mol Med
Suresh V, Hafemeister C, Konstantinou A, Grissenberger S, Sturtzel C, Zylka MM, Cidre-Aranaz F, Wenninger-Weinzierl A, Queiroz K, Kurek D, Distel M, Obenauf A, Grünewald TGP, Halbritter F, Kovar H, Fock V.   +15 more
europepmc   +1 more source

Alternative Splicing: A Critical Regulator in Human Bone Biology and Tumor Progression. [PDF]

Research (Wash D C)
Cao L, Hu Y, Jia K, Ruiz-Cardozo MA, Chen E, Yang J, Shao Z, Van Tine BA, Wu W.   +8 more
europepmc   +1 more source

RUNX2 Represses the EWS-FLI1-mediated Transcription in Ewing's Sarcoma Cells. [PDF]

Cancer Genomics Proteomics
Kitagawa T, Baron B, Okita H, Hamada J, Nakagawa K, Kobayashi M, Ohta T, Kuramitsu Y.   +7 more
europepmc   +1 more source

The Goldilocks paradox: when partial oncoprotein inhibition fuels metastasis in Ewing sarcoma. [PDF]

EMBO Mol Med
Castets M, Bertrand-Chapel A, Blay JY.
europepmc   +1 more source

FET fusion oncoproteins enrich SWI/SNF complex subtypes and interaction partners. [PDF]

Cell Mol Biol Lett
Lindén M, Andersson L, Albatrok H, Canfjorden V, Jonasson E, Grönqvist K, Sjövall D, Jaako P, Crescitelli R, Fagman H, Åman P, Ståhlberg A.   +11 more
europepmc   +1 more source

p300/CBP is an essential driver of pathogenic enhancer activity and gene expression in Ewing sarcoma. [PDF]

EMBO Rep
Godfrey LC, Regalado B, Schweber SR, Hatton C, Wenge DV, Wen Y, Boileau M, Wessels M, Qi J, Ott CJ, Stegmaier K, Rivera MN, Armstrong SA.   +12 more
europepmc   +1 more source

Potential biomarkers of Ewing sarcoma identified through a Europe-wide analysis of prospectively collected samples. [PDF]

Sci Rep
Ranft A, Richter GHS, Diaz-Martin J, Jabar S, Jens M, Kerkhoff M, Blanquer-Maceiras M, Noguera R, Piro I, Steiger K, Burdach S, Parra A, Picci P, Gambarotti M, Hartmann W, Scotlandi K, de Alava E, Dirksen U.   +17 more
europepmc   +1 more source